These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 18048825

  • 1. Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients.
    Ives NJ, Stowe RL, Lorigan P, Wheatley K.
    J Clin Oncol; 2007 Dec 01; 25(34):5426-34. PubMed ID: 18048825
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG).
    Hauschild A, Garbe C, Stolz W, Ellwanger U, Seiter S, Dummer R, Ugurel S, Sebastian G, Nashan D, Linse R, Achtelik W, Mohr P, Kaufmann R, Fey M, Ulrich J, Tilgen W.
    Br J Cancer; 2001 Apr 20; 84(8):1036-42. PubMed ID: 11308250
    [Abstract] [Full Text] [Related]

  • 4. Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.
    Bedikian AY, Johnson MM, Warneke CL, McIntyre S, Papadopoulos N, Hwu WJ, Kim K, Hwu P.
    J Immunotoxicol; 2008 Apr 20; 5(2):201-7. PubMed ID: 18569391
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy.
    Legha SS.
    Semin Oncol; 1997 Feb 20; 24(1 Suppl 4):S39-43. PubMed ID: 9122733
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of metastasized malignant melanoma].
    Kamanabrou D.
    Praxis (Bern 1994); 2001 Mar 08; 90(10):391-6. PubMed ID: 11305184
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Complex combination biochemotherapy regimen in advanced metastatic melanoma in a non-intensive care unit: toxicity or benefit?
    Hofmann MA, Sterry W, Trefzer U.
    Jpn J Clin Oncol; 2007 Mar 08; 37(3):224-9. PubMed ID: 17472972
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chemotherapy and chemoimmunotherapy in disseminated malignant melanoma.
    Garbe C.
    Melanoma Res; 1993 Aug 08; 3(4):291-9. PubMed ID: 7693093
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients.
    Bruzzi P, Del Mastro L, Sormani MP, Bastholt L, Danova M, Focan C, Fountzilas G, Paul J, Rosso R, Venturini M.
    J Clin Oncol; 2005 Aug 01; 23(22):5117-25. PubMed ID: 15955906
    [Abstract] [Full Text] [Related]

  • 18. New approaches to the systemic treatment of melanoma.
    Chowdhury S, Vaughan MM, Gore ME.
    Cancer Treat Rev; 1999 Oct 01; 25(5):259-70. PubMed ID: 10544070
    [Abstract] [Full Text] [Related]

  • 19. Treatments for metastatic melanoma: synthesis of evidence from randomized trials.
    Lui P, Cashin R, Machado M, Hemels M, Corey-Lisle PK, Einarson TR.
    Cancer Treat Rev; 2007 Dec 01; 33(8):665-80. PubMed ID: 17919823
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.